SEC Form 4 · accession 0001554795-15-000243
IRIS BIOTECHNOLOGIES INC · IRSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon Chin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 2:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | P | 1,000 | $0.50 | A | 7,173,647 | D | |
| Common Stock | May 20, 2015 | P | 500 | $0.60 | A | 7,174,147 | D | |
| Common Stock | May 20, 2015 | P | 100 | $0.895 | A | 7,174,247 | D | |
| Common Stock | May 21, 2015 | P | 100 | $0.895 | A | 7,174,347 | D | |
| Common Stock | May 22, 2015 | P | 500 | $0.895 | A | 7,174,847 | D |
Table II — derivative securities
No Table II lines on this filing.